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Abstract 
Specific Phobia of Vomiting (SPOV) is an under-researched disorder compared to other 
Specific Phobias. A systematic review was conducted to synthesise existing research across 
areas of phenomenology, aetiology, epidemiology, co-morbidity, assessment measures and 
treatment.  
Online databases (Psychinfo, Embase, Medline, Pubmed and Cochrane Library) were 
searched using terms related to SPOV and ‘emetophobia’. A manual search of reference lists 
of included papers was also conducted. In total, 385 articles were found and 24 were included 
in the review. The review was registered on the PROSPERO register (CRD42016046378). 
The review presents a qualitative synthesis of identified studies exploring the features of 
SPOV including locus of fear, feared consequences of vomiting, and common safety and 
avoidance behaviours. It also identified articles describing aetiological factors involved in the 
development of SPOV, co-morbid disorders and the epidemiology of the disorder. Further 
studies focused on valid and reliable measures to assess SPOV, and treatments that are 
effective at reducing symptomatology of SPOV and psychological distress. 
There are relatively few published research articles on SPOV, and particularly high quality 
studies exploring effective treatment options for SPOV. Further research should focus on 
RCTs for comparing different approaches to reducing symptomatology and distress in people 
with SPOV.  
 
Keywords: specific phobia vomiting; SPOV; emetophobia; anxiety disorders; cognitive 
behavioral therapy; fear of vomiting  
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Introduction 
SPOV: An Overview 
Specific Phobia of Vomiting (SPOV), also known as ‘emetophobia’, is categorized as a 
‘Specific Phobia: Other’ subtype in DSM-V, involving a persistent fear of vomiting which is 
disproportional to the threat or danger posed by such an outcome (American Psychiatric 
Association, 2013; World Health Organization, 1992). Fear of vomiting will often lead to 
persistent avoidance of vomit or nausea-related activities or situations (World Health 
Organization, 1992). Individuals with SPOV typically fear themselves vomiting more than 
other people (Lipsitz, Fyer, Paterniti, and Klein, 2001; Veale & Lambrou, 2006); and a 
proportion fear vomiting in public as well as vomiting alone (Holler, van Overveld, Jutglar, 
& Trinka, 2013; Veale & Lambrou, 2006). The reported prevalence rate of SPOV varies; 
however, it is commonly thought to be rare in community samples (Becker et al., 2007).  
SPOV is conceptualised as a Specific Phobia; however, there are ways in which it differs to 
other phobias. For example, SPOV is widely recognised to be more prevalent in women 
across the majority of studies. The reported prevalence rate of SPOV and a fear of vomiting 
varies; however, community prevalence rates also suggest that SPOV is relatively rare 
compared to other Specific Phobias (Becker et al., 2007). However, clinically many more 
people with SPOV may present to services. Additionally there is significant overlap between 
the features of SPOV and other disorders, such as OCD, health anxiety and disordered eating 
(Veale, Costa, Murphy, & Ellison, 2012; Veale, Murphy, Ellison, Kanakam, & Costa, 2013). 
SPOV may therefore be more difficult to recognise and diagnose compared to other phobias, 
and therefore the path to specialist treatment may be hindered. This may further explain the 
underestimation of prevalence rates in community and clinical samples (Boschen, 2007; 
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Veale, 2009). Furthermore, the feared stimuli central to SPOV are often interoceptive cues 
that occur daily such as gastric complaints or nausea. This may have implications regarding 
the development of SPOV and the degree of interference in daily life compared to phobias of 
external cues that can more easily be avoided. Lastly, SPOV is generally considered by 
clinicians as hard to treat. The evidence-based treatment of choice for a specific phobia is 
graded exposure (Wolitzky-Taylor, Horowitz, Powers & Telch, 2008). However, a survey by 
Lipsitz, Fyer, Paterniti, and Klein (2001) found that only 6% of individuals with fear of 
vomiting were willing to try exposure; 54% definitely would not try it and 36% were unsure. 
Treatment of SPOV may be further complicated by complex features such as rituals or 
compulsions, disordered eating and low BMI, other misdiagnoses, high dropout rates and 
difficulties with repeated exposure to vomiting (van Hout & Bouman, 2012; Veale, 2009; 
Veale & Lambrou, 2006).  
Objectives 
SPOV can be considered different to other Specific Phobias with regard to aetiology, 
complexity and treatment options. However, due its conceptualisation as a ‘Specific Phobia: 
Other’, research into the clinical features and treatment options specific to fear of vomiting is 
limited, with only one RCT to date. This review is therefore needed to highlight gaps and 
limitations in the current literature, in order to provide recommendations for further research.  
The review will include a narrative synthesis of existing literature across the following 
domains: 
a) What is currently known about the phenomenology of SPOV? 
b) What is the prevalence rate of SPOV? 
c) What are the aetiological factors associated with SPOV? 
d) Which disorders are commonly comorbid with SPOV? 
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e) Are there any valid and reliable measures for assessing SPOV? 
f) Which treatments are effective at reducing the symptomatology of SPOV? 
Methods 
Design 
A systematic review of the literature was conducted and a qualitative synthesis of the results 
are presented. The review was registered on the PROSPERO register CRD42016046378. 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016046378 
Search criteria 
Search terms for all databases were “specific phobia of vomit*”, “emetophob*”, “fear of 
vomit*”, “phob* of vomit*” and “vomit* phob*”. 
Selection procedure 
Databases included in the search were Pubmed, Psychinfo, Embase, Medline and the 
Cochrane library. The final search was undertaken on 9
th 
May 2016. All research studies on 
SPOV that were published in English from 1846 to May 2016 were eligible for inclusion in 
the review. The population of studies included in the review were people of any age with a 
diagnosis of or presenting with symptoms of SPOV, or fear of vomiting. We included case 
series, cohort studies and controlled trials. Included outcome measures were measures of 
SPOV symptomatology (self-reported symptoms e.g. visual analogues scales), psychological 
symptoms or measures of distress, measures of avoidance behaviours and body mass index. 
Intervention studies for all types of psychological intervention were included.  
Titles, abstracts and full articles were screened in stages by two independent reviewers. Inter-
rater agreement between reviewers across stages was 96.1%. Disagreement was resolved by a 
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third party (DV). A manual review of reference lists of final included papers was also 
conducted to identify additional papers for inclusion (n=3).  
Data collection 
Data was extracted by the same two independent reviewers and entered separately into forms 
with variables including study design, patient characteristics, mean age, intervention (where 
relevant), measures and main findings. Data was reviewed and collated into tables by the first 
author (AK). 
Risk of bias 
Two instruments were used to assess risk of bias across studies: one for 
observational/epidemiological studies and one for intervention studies. An 8-point tool was 
developed by Matcham et al. (2014) based on the Strengthening of Observational Studies in 
Epidemiology (STROBE) statement to assess observational studies. This tool assessed and 
allocated points to each study based on the method of sampling used, the sample size, 
participation rate and the eligibility criteria for participation. Articles were scored using the 
following overall scale of low (0-2), medium (3-5) and high (6-8) quality. A similar tool was 
adapted for use in this review, with additional criteria based on methods used to detect 
Specific Phobia. This tool was scored overall out of 10 and the following scale was used: low 
(0-2), medium (3-5) and high (6-10) quality (Appendix A). Risk of bias was assessed by two 
independent reviewers, with an agreement rate of 91.7% for global ratings across both 
assessment tools. Disagreements were discussed and agreed by consensus. For intervention 
studies, the EPHPP Quality Assessment Tool for Quantitative Studies was used (Appendix 
B). Studies were rated weak, moderate or strong across 6 domains: selection bias, study 
design, confounders, blinding, data collection methods and withdrawals and dropout. Studies 
with two or more weak ratings were given a global rating of weak; studies with one weak 
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rating was given a moderate rating and a strong rating was given for studies with no weak 
ratings. Quality ratings for each study can be seen in Table 1a&b. 
Results 
Articles were split into three categories and presented accordingly: 1) diagnosis and 
phenomenology, 2) epidemiology, aetiology and comorbidity and 3) assessment and 
treatment of SPOV. Two further tables present data for common features of SPOV (Table 3) 
and co-morbid disorders (Table 5) across studies. Where papers cover more than one topic, 
data have been added separately into relevant tables. Weighted averages of percentages were 
calculated across studies and sample sizes. 
Quality assessment 
Scores for each domain and global scores for observational studies are presented in Table 1a, 
and intervention studies in Table 1b. Across observational studies, only 2 scored in the high 
quality range (Becker et al., 2007; Norris et al., 2014). The majority of studies were rated as 
medium quality (n=12) and n=6 were rated low quality. Notably, many studies exploring the 
phenomenology of SPOV used surveys of community or internet samples. n=8 studies scored 
0 for sampling methodology, suggesting samples may not be likely to be representative of the 
target population. The majority of observational studies used relatively small sample sizes 
(n=19). There were n=20 single case intervention studies that were excluded from the review 
as quality could not be rated based on the criteria used. Only two of the included treatment 
studies scored in the moderate range (Ahlen, Edberg, Di Schiena, & Bergström, 2015; 
Riddle-Walker et al., 2016) and the other two scored in the weak range (Klonoff, Knell, & 
Janata, 1984; Philips, 1985), demonstrating the lack of high quality research exploring 
effective interventions for SPOV.  
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Results of individual studies 
 
Diagnosis and phenomenology of SPOV 
Two papers explored the validity of the SPOV diagnosis (Himle, McPhee, Cameron, & 
Curtis, 1989; Lelliott, McNamee, & Marks, 1991) (Table 2). These studies were conducted 
prior to the change in name to Specific Phobia. Four diagnostic categories of Simple Phobia 
were supported by significant between group differences in clinical and epidemiological 
variables, such as gender, age of onset and family history of Simple Phobia. One study found 
that fewer patients with fears of vomiting or incontinence are assigned to a correct diagnosis 
compared to those with Social Phobia or Agoraphobia (Lelliott et al., 1991). People with 
SPOV were also found to differ from the clinical and demographic profiles of those with 
other phobias e.g. younger age of onset; more likely to be female and greater restrictions in 
terms of use of public transport (Lelliott et al., 1991).  
Ten studies explored the phenomenology of SPOV and found that increased nausea, intrusive 
imagery of vomiting, disgust and locus of control were significant features of SPOV 
(Davidson, Boyle, & Lauchlan, 2008; Holler et al., 2013; Lelliott et al., 1991; Lipsitz et al., 
2001; Price, Veale, & Brewin, 2012; van Hout & Bouman, 2012; van Overveld, de Jong, 
Peters, van Hout, & Bouman, 2008; Veale & Lambrou, 2006; Verwoerd, van Hout, & de 
Jong, 2016; Wu, Rudy, Arnold, & Storch, 2015) (Table 2). 80.6% of SPOV patients reported 
intrusive imagery about vomiting including intrusive early memories of vomiting (31%) and 
flash-forwards e.g. imagining worst case scenarios (17%) (Price et al., 2012). Imagery in 
SPOV was associated with higher SPOV symptomatology, food restriction, obsessive-
compulsive symptoms, health anxiety and significant impairment in several areas of adaptive 
functioning (Price et al., 2012).  
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Locus of fear 
Seven studies explored the locus of the fear in individuals with SPOV (Holler et al., 2013; 
Lipsitz et al., 2001; Price et al., 2012; van Hout & Bouman, 2012; Veale & Lambrou, 2006; 
Veale, Murphy, et al., 2013; Wu et al., 2015) (Tables 2 and 4). The rate of fear of self-
vomiting across all SPOV samples was 47.3% (n=366); fear of others vomiting was 12.7% 
(n=331) and equal fear of both outcomes was 35.5% (n=699) (Table 3). Fears of other people 
vomiting may be due to fears that vomiting in others may be contagious which may lead to 
vomiting themselves (van Hout & Bouman, 2012). Fear around vomiting in public vs. private 
situations were less consistently studied (n=3). Fear of vomiting in public was found in 
47.9% of all SPOV samples (n=409); vomiting in private was 3% (n=166) and equal fear of 
both situations was 55.6% across samples (n=188). A SPOV sample were also found to  score 
significantly higher on internal loss of control across both general and health domains 
compared to phobic (not SPOV) and nonphobic controls, suggesting that individuals with 
SPOV may fear vomiting in the context of a fear of losing control (Davidson et al., 2008).  
Feared consequences of vomiting 
Three studies explored the feared consequences of vomiting in SPOV samples (Holler et al., 
2013; van Hout & Bouman, 2012; Veale, Murphy, et al., 2013) (Tables 2 and 4). Feared 
outcomes included fear of getting contaminated and becoming ill (50.5%, n=113); fear of 
nausea and vomiting (100%, n=19); fear of a heart attack (30.4%, n=128); fear of panic 
(29.4%, n=34); fear of losing control (19.1%, n=165); the features of vomit (e.g. sight [72%], 
sound [71%], taste [4.8%] or smell [66%]); self-disgust (33%), n=131; suffocation (37.3%, 
n=131) and gagging (83.8%, n=131) (Table 3).  
Safety seeking behaviours 
Six papers reported data on safety seeking behaviours in SPOV samples (Lipsitz et al., 2001; 
Price et al., 2012; van Hout & Bouman, 2012; Veale et al., 2012; Veale, Hennig, & Gledhill, 
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2015; Veale & Lambrou, 2006) (Tables 2 and 4). In an attempt to reduce the likelihood of 
vomiting, 64.9% (n=296) checked expiry dates on food; 42.1% (n=183) washed their hands 
excessively; 16% (n=100) checked the state of their own health; 80.8% (n=83) checked the 
state of other peoples’ health. 44.9% (n=211) of females with SPOV avoided or postponed 
pregnancy; 5.3% (n=5) of females with SPOV reported terminating a pregnancy; 34% (n=32) 
avoided anaesthesia or surgery; 62.4% (n=94) reported over-cooking their food; 40.3% 
(n=233) described engaging in eating rituals; 52.7% (n=83) reassured themselves and 30% 
(n=183) sought reassurance from others due to fear of vomiting (Table 3).  
Avoidance behaviours 
Four studies presented data on people or situations that are commonly avoided by people with 
SPOV (Holler et al., 2013; Price et al., 2012; van Hout & Bouman, 2012; Veale & Lambrou, 
2006) (Table 2). These include people at risk of vomiting e.g. ill people (80.8%, n=119), 
drunk people (85.9%, n=119), foreign countries (71.1%, n=119), alcohol (65.6%, n=119), 
food (84.6%, n=167), illegal substances (92.3%, n=100), travel by boat (89.3%, n=100), 
plane (68.7%, n=100) or public transport (64.4%, n=100) (Table 3).  
Three papers explored avoidance behaviours specifically around food (Holler et al., 2013; 
Veale et al., 2012; Veale & Lambrou, 2006) (Tables 2 and 4). 63.1% (n=100) of people with 
SPOV avoided eating from salad bars or buffets; 54.1% (n=100) avoided eating in 
restaurants; and 55.7% (n=100) avoided pubs. People with SPOV also avoided specific types 
of foods due to their fears of vomiting e.g. foreign foods (32.1%, n=194), shellfish (65.7%, 
n=194), meat (45.6%, n=325), fish (14.4%, n=131), dairy (17.6%, n=325) or eggs (22.3%, 
n=225) (Table 3).  
Impairment/quality of life 
Two papers reported the percentage of patients who reported a negative impact of SPOV 
symptomatology on quality of life and mean interference out of 10 across several life 
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domains (Lipsitz et al., 2001; Veale & Lambrou, 2006). People with SPOV reported 
impairments in social functioning e.g. avoiding parties where there may be alcohol (62%, 
m=6.7, SD=2.8), occupational functioning e.g. having to leave work frequently (19.6%, 
m=5.4, SD=3.6) education e.g. skipping classes (9%), leisure e.g. difficulty with travel or 
going to new places (70%), and home marital life e.g. postponing/avoiding pregnancy or 
being left alone with young children (34%, m=4.8, SD=3.4) (Lipsitz et al., 2001; Veale & 
Lambrou, 2006) (Table 2).  
Epidemiology, Aetiology and Comorbidity 
Epidemiology  
All studies reported higher rates of female participants across samples (83.2%, n=1738). 
Three studies explored prevalence rates of SPOV and a fear of vomiting in community 
samples (Becker et al., 2007; van Hout & Bouman, 2012; Wu et al., 2015) (Tables 2 and 4). 
A lifetime prevalence rate of 0.2% was reported (Becker et al., 2007). Compared to other 
Specific Phobias, this estimate is significantly lower (animals 4.5, heights 1.7, blood injection 
injury 1.9, situational 2.2) (Becker et al., 2007). Point prevalence rates of fear of vomiting 
(not a phobia) were found to be 1.8% for men and 7% for women (van Hout & Bouman, 
2012) and in an adolescent sample, 7.5% were found to have elevated SPOV symptoms (Wu 
et al., 2015).  
Aetiology 
Four papers explored aetiological factors in the development of SPOV (Himle et al., 1989; 
Lipsitz et al., 2001; Veale, Murphy, et al., 2013; Verwoerd et al., 2016) (Tables 2 and 4). 
Memories of aversive experiences of self or others vomiting were found to be significant 
factors in the development of SPOV (Lipsitz et al., 2001; Veale, Murphy, et al., 2013). 
Higher SPOV symptoms were found to be associated with higher disgust propensity and 
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sensitivity (Verwoerd et al, 2016). Furthermore, disgust and anxiety based emotional 
reasoning was found to significantly predict high and low fear of vomiting, suggesting that 
disgust and emotional reasoning may play a role in the development of SPOV (Verwoerd et 
al, 2016).   
Co-morbidity 
Four studies explored comorbidity between SPOV and other Axis I disorders (Sykes, 
Boschen, & Conlon, 2015) and specifically Eating Disorders (Norris et al., 2014; Veale et al., 
2012), OCD (Veale et al., 2015) and Health Anxiety (Veale et al., 2015)  (Table 4). Co-
morbidity rates for Axis 1 disorders found across all samples of SPOV are presented in Table 
5.  
Assessment measures and treatment 
Measures 
Two self-report measures have been validated for use in the assessment of SPOV (Boschen, 
Veale, Ellison, & Reddell, 2013; Veale, Ellison, et al., 2013) (Table 6). The Specific Phobia 
of Vomiting Inventory (SPOVI) and the Emetophobia Questionnaire (EmetQ) were found to 
be reliable and valid measures of SPOV symptoms, with good internal consistency, test-retest 
reliability (Boschen et al., 2013). The EmetQ was found to have good sensitivity and 
specificity in determining cases of SPOV (Boschen et al., 2013; Veale, Ellison, et al., 2013). 
Similarly, the SPOVI demonstrated good sensitivity to change over time, and a clinical cut-
off score of 10 was identified (Veale, Ellison, et al., 2013).  
A Behavioural Avoidance Test (BAT) was developed to measure ability to approach a vomit-
like stimulus (Boschen et al, 2013). Participants were asked to approach a fake vomit mixture 
and scored on level of approach (e.g. 0=able to immerse both hands and smell the vomit 
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stimulus to 10=avoids the task after it is described). Higher scores reflected higher levels of 
avoidance. No observer rated measures of SPOV have been developed. 
Past treatment 
Five studies explored the treatment histories of patients with SPOV (Holler et al., 2013; 
Lipsitz et al., 2001; van Hout & Bouman, 2012; Veale et al., 2012; Veale & Lambrou, 2006) 
(Tables 2 and 4). The majority of cases sought medical advice from their GP (74.5%, n=231); 
and over one third had been prescribed anti-nausea or anti-depressant medication (38.7%, 
n=156). 67% (n=100) of patients with SPOV had been referred to a psychologist or 
psychiatrist and only 25.8% (n=175) had received some form of psychotherapy (17.9% CBT, 
20.3% BT and 35% hypnotherapy, n=100) (Table 3).  
Treatment effectiveness 
Only four treatment studies were included in the review (Ahlen et al., 2015; Klonoff et al., 
1984; Philips, 1985; Riddle-Walker et al., 2016) (Table 6). Twenty published single case 
studies were identified in the search and excluded. There is only one published RCT (Riddle-
Walker et al., 2016). Two studies explored the effectiveness of group CBT (Ahlen et al., 
2015; Philips, 1985); one explored individual CBT including imagery rescripting (Riddle-
Walker et al., 2016) and one explored contingency management, parent training and 
relaxation (Klonoff et al., 1984). All studies reported reductions in SPOV symptomatology 
over time, which were maintained at follow up (Ahlen et al., 2015; Klonoff et al., 1984; 
Philips, 1985). Both group and individual CBT were associated with clinical significant and 
reliable change, and reductions in associated anxiety and depression (Ahlen et al., 2015; 
Riddle-Walker et al., 2016). Group CBT was found to be associated with high client 
satisfaction (Ahlen et al., 2015). Effect sizes for reductions in SPOV symptomatology were 
strong and significant (EmetQ: 0.85-1.52 treatment phase, 1.18 follow up; SPOVI 1.52 
treatment phase) (Ahlen et al., 2015; Riddle-Walker et al., 2016). 
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Discussion 
Phenomenology of SPOV 
Most included studies exploring clinical features used clinic, internet and community samples 
(n=10). Almost half of individuals with SPOV fear mainly themselves vomiting and roughly 
one third fear themselves and others vomiting equally. In the latter cases, it may be that fear 
of others vomiting is due to exposure to the vomit itself or the fear of infection from others 
that may increase the risk of self-vomiting (van Hout & Bouman, 2012). SPOV was linked to 
a high degree of anxiety and distress (Lipsitz et al., 2001; van Hout & Bouman, 2012; Veale 
& Lambrou, 2006). Individuals with SPOV report gastric complaints (van Hout & Bouman, 
2012) and experience nausea almost every day (Holler et al., 2013; Veale & Lambrou, 2006), 
especially when anxious (Holler et al., 2013). Nausea is not reported to lead to actual 
episodes of vomiting; however, it is associated with high levels of distress and anxiety 
(Holler et al., 2013; Veale, 2009). This may be due to the appraisal of nausea as a signal of 
impending threat i.e. an episode of vomiting; which leads to anxiety and safety seeking 
behaviours to reduce the likelihood of vomiting occurring (Veale, 2009). Individuals with 
SPOV were found to have higher disgust propensity and disgust sensitivity (van Overveld et 
al., 2008); higher internal locus of control, particularly relating to health (Davidson et al., 
2008), and higher disgust based emotional reasoning (Verwoerd et al, 2016). Individuals with 
SPOV may therefore associate vomiting with losing control of one’s bodily functions and/or 
lack of perceived control over their physical health.  
Three studies explored the feared consequences of vomiting (Holler et al., 2013; van Hout & 
Bouman, 2012; Veale, Murphy, et al., 2013). van Hout and Bouman (2012) developed 8 
categories of feared consequences of vomiting and found that the most frequent fears 
included getting contaminated and becoming ill; loss of control and panic. All participants 
agreed to ‘fear of vomiting and nausea’ as a feared consequence. However, it remains unclear 
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whether this is an evaluation of the awfulness of the experience of vomiting, or an actual 
feared consequence of vomiting. It may be that people with SPOV find it hard to describe 
their fears in relation to vomiting. In addition, individuals with SPOV may be encouraged to 
rationalise or ascribe their fears to pre-determined categories i.e. for research or during 
treatment. This post-hoc description of feared outcomes may be difficult to distinguish 
between feared consequences of vomiting and the evaluations of vomiting itself.  
Fear of vomiting is linked to intrusive memories of early aversive experiences of vomiting 
(Price et al., 2012; Veale, Murphy, et al., 2013). Similar to a cognitive model of trauma, old 
memories of vomiting may be ‘triggered’ in individuals with SPOV and experienced with a 
sense of ‘nowness’, which maintains a current sense of threat in relation to vomiting (Veale, 
2009). Almost a third of individuals with SPOV experience intrusive imagery of early 
experiences of vomiting, and almost one half experience imagery with a sense of ‘nowness’ 
(Price et al., 2012). Thus the role of imagery may be important in maintaining SPOV, in that 
flashbacks of sounds, smells and physical sensations associated with early aversive memories 
may maintain the fear of vomiting. Two models may therefore explain the maintenance of 
SPOV, one is similar to panic in that normal bodily sensations are misinterpreted as an 
impending episode of vomiting and losing control. In addition, the evaluation of vomiting is 
of extreme awfulness. In contrast, for those that experience intrusive imagery, the fear may 
be triggered by an association with fragments of past aversive memories of vomiting. 
In order to cope with nausea and fear of vomiting, individuals often develop various safety 
seeking and avoidance behaviours to reduce the likelihood of their self or others vomiting or 
the intolerance of uncertainty about whether they may vomit. These include food restriction; 
excessive checking of expiration dates before eating; frequent hand washing and cleaning; 
reassurance seeking; using mints or antacids to reduce nausea; avoiding drunk or sick people, 
pregnancy, travel or holidays abroad, (Lipsitz et al., 2001; Price et al., 2012; van Hout & 
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Bouman, 2012; Veale et al., 2012; Veale & Lambrou, 2006; Veale, Murphy, et al., 2013). 
Fear and avoidance of anxiety-provoking situations can be chronic and disabling with 
profound disruption to daily life e.g. work, leisure, social relationships and home life 
(Davidson et al., 2008; Lipsitz et al., 2001; Veale & Lambrou, 2006).   
Due to a lack of research on SPOV phenomenology, more experimental studies are needed to 
identify the processes that maintain fear of vomiting. Specifically, research may explore how 
safety seeking and avoidance behaviours maintain or increase this fear. For example, further 
research may help to clarify the function of certain behaviours, which have a lot of 
similarities to obsessive compulsive disorders e.g. checking on the likelihood of the threat (of 
vomiting), undoing or reversing the threat of vomiting (like compulsive washing), or 
avoiding/preventing vomiting, and how these contribute to the maintenance of SPOV. 
Epidemiology 
All studies found a higher proportion of female participants with SPOV (83.2%, ratio 4.95:1).  
This gender ratio is higher compared to a reported ratio of between 2 and 4:1 found in 
Specific Phobias (Bekker & van Mens-Verhulst, 2007; Somers, Goldner, Waraich, & Hsu, 
2006). To date, little is known regarding the higher female prevalence of SPOV compared to 
other phobias. In contrast to Specific Phobias, prevalence rates of SPOV vary; however, in 
one study it was found to be rare in community samples, compared to other Specific Phobias 
(Becker et al., 2007). In children and adolescents, reported prevalence rates of Specific 
Phobias varies from 0.22% (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003) to 23.9% 
(Muris, Schmidt, & Merckelbach, 1999). It is therefore difficult to compare prevalence rates 
between SPOV and Specific Phobias in this age group.  
Despite variations in reported rates, community rates may be at odds with what is seen 
clinically. For example, Vandereycken (2011) found that 48.5% of eating disorder clinicians 
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had encountered SPOV in their patients. This suggests that there may be higher prevalence of 
SPOV in clinical samples, and that patients with SPOV may be mis-diagnosed with other 
disorders such as AN, OCD or health anxiety (Vandereycken, 2011; Veale, Murphy, et al., 
2013). For accurate diagnoses, it is important for clinicians to understand the motivations 
behind avoidance and safety behaviours such as food restriction or compulsive washing. A 
SPOV must be clearly distinguished from other disorders as a fear of vomiting as the main 
presenting problem. Avoidance and safety behaviours may be driven by the same motivation 
to keep safe from feared outcomes across all disorders. However, the content of the fear may 
be broader for other diagnoses compared to SPOV e.g. fear of gaining weight in AN, 
contamination from dirt and germs in OCD, and contracting any serious illness in health 
anxiety, not just in the context of vomiting. The temporal history of fears may also differ in 
these disorders compared to SPOV. For example, a person with a SPOV fears contamination 
and/or illness in relation to likelihood of vomiting only, whereas individuals with health 
anxiety may have a history of fearing a wider range of illness in the past.  
Aetiology 
Two models explain the importance of aversive memories, internal cues and other 
maintenance factors in the development of SPOV. Boschen (2007) suggests that individuals 
learn to interpret internal cues such as nausea as an indication of imminent vomiting which 
leads to increased anxiety and GI symptoms. This vicious circle is then maintained by 
changes in attentional biases towards internal cues, worry and avoidance behaviours 
(Boschen, 2007). Another model emphasises the importance of aversive memories of 
vomiting that become associated with fear, which leads to a re-experiencing of various cues 
as if these memories are about to be repeated (Veale, 2009). The core appraisal in this model 
is that nausea is suggestive of an imminent vomiting episode of extreme threat and awfulness, 
which leads to anxiety and further nausea. Similar to Boschen’s model, the fear of vomiting 
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is then maintained by avoidance, hypervigilance to threat cues, self-focussed attention and 
self-monitoring, worry, self-assurance, safety behaviours and an over-inflated sense of 
responsibility of control over vomiting (Veale, 2009). Furthermore, disgust and emotional 
reasoning may play a role in the development of SPOV. Verwoerd et al (2016) found that 
higher SPOV symptoms were associated with higher disgust propensity and sensitivity. In 
addition, emotional reasoning used to determine risk of becoming ill was found to be most 
pronounced in a more severe SPOV group. These findings suggest that a higher sensitivity to 
disgust and disgust based emotional reasoning may play a role in the development of 
persistent and erroneous beliefs regarding vomiting in SPOV (Verwoerd et al, 2016), and 
may add to existing conceptual models of SPOV. Relatively few included studies explore 
developmental factors in SPOV (n=4). An internet survey by Lipsitz et al. (2001) showed that 
individuals with fear of vomiting present with past experiences of self (29%) and others 
(59%) vomiting which were distressing. Aversive memories of vomiting were also shown to 
be significantly more distressing in individuals with SPOV and may be a significant 
aetiological factor in its development (Veale, Murphy, et al., 2013). However, both studies 
were rated as low (Lipsitz et al., 2001) and medium (Veale, Murphy, et al., 2013) quality. 
Therefore, more experimental research is needed to support developmental models, replicate 
findings and improve generalizability in patients diagnosed with SPOV.  
Co-morbidity 
Research into comorbidity is important as SPOV is often mis-diagnosed in clinical settings 
due to significant overlap in clinical features with other presentations. However, relatively 
few papers exploring co-morbidity in SPOV exist (n=4).  Axis I disorders associated with 
SPOV include anxiety disorders (panic disorder, social phobia, agoraphobia and OCD), 
depression and eating disorders (Becker et al., 2007; Davidson et al., 2008; Lipsitz et al., 
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2001; Norris et al., 2014; Sykes et al., 2015; van Hout & Bouman, 2012; Veale, Murphy, et 
al., 2013).  
One paper explored the overlap between clinical features of SPOV and OCD (Veale et al., 
2015) e.g. compulsive washing, reassurance seeking and checking. Verwoerd et al (2016) 
found that vomit fearful subjects use emotional response information such as disgust and 
anxiety to infer heightened risk of contamination and risk of becoming ill. Fears of 
contamination have also been reported in people with SPOV, in relation to catching illnesses 
that may make vomiting more likely (Veale & Lambrou, 2006). Compulsive behaviours 
similar to those seen in OCD are then employed to reduce the likelihood of vomiting (Veale 
et al., 2015; Veale & Lambrou, 2006). The overlap between features suggests that there is a 
continuum between pure specific phobias at the mild end of the spectrum to OCD at the more 
severe end. However, it is important to distinguish true cases of OCD i.e. whether features 
are solely in the context of a fear of vomiting or relevant to a broader range of fears such as 
contamination in the context of dirt or germs. Co-morbid OCD is only likely in the event that 
there are additional obsessions and compulsions not related to fear of vomiting.  
Panic attacks related to fear of vomiting are also experienced by individuals with SPOV. 
Certain fears reported in SPOV are similar to those with Panic Disorder e.g. fears of choking, 
fainting or dying after vomiting (Veale & Lambrou, 2006).  However, an additional diagnosis 
of Panic disorder is only indicated if panic attacks occur in situations not related to fear of 
vomiting. Lastly, a proportion of individuals with SPOV fear vomiting in public more than 
vomiting alone, suggesting that these individuals fear negative evaluation, shame and 
rejection from others which is commonly seen in people with Social Anxiety Disorder 
(McNally, 1997; Veale & Lambrou, 2006). These fears are best conceptualised as a SPOV if 
the main feared outcome is vomiting in front of others, and no other performance-related 
concerns are evident. 
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Research suggests that there may be significant overlap between SPOV and other Axis-I 
disorders. However, true comorbidities should only be diagnosed in cases where cognitions 
and behaviours are not related to fears of vomiting. The four studies on treatment included in 
the review are of medium to high quality; however, more research is required to explore 
similarities between features of SPOV and other disorders, to prevent misdiagnosis and 
improve access to specialist treatment. 
Assessment and Treatment of SPOV 
Two standardised measures were shown to be reliable and validated tools in the assessment 
of SPOV, with good inter-rater reliability, validity, sensitivity and specificity (Boschen et al., 
2013; Veale, Ellison, et al., 2013). The SPOVI was shown to have a clinical cut off score of 
10 (Veale, Ellison, et al., 2013). The development of standardised behavioural avoidance 
tests or other observer rated scales to improve methodology in SPOV research may be 
beneficial. 
Research into the effectiveness of psychological treatments for SPOV is limited to mostly 
case reports and studies with small samples. To date, only one RCT has been published 
comparing the effectiveness of CBT to wait list control (Riddle-Walker et al., 2016). Most 
case reports suggest that SPOV can be treated successfully by CBT (Graziano, Callueng, & 
Geffken, 2010; Hunter & Antony, 2009; Kahana & Feeny, 2005; Kobori, 2011; Pollard, Tait, 
Meldrum, Dubinsky, & Gall, 1996; Whitton, Luiselli, & Donaldson, 2006), behavioral 
approaches (Faye, Gawande, Tadke, Kirpekar, & Bhave, 2013; Herman, Rozensky, & 
Mineka, 1993; Lesage & Lamontagne, 1985; Maack, Deacon, & Zhao, 2013; McFadyen & 
Wyness, 1983; Philips, 1985; Williams, Field, Riegel, & Paul, 2011); systemic behaviour 
therapy (O'Connor, 1983); psychotherapy (Manassis & Kalman, 1990); hypnotherapy 
(McKenzie, 1994; Ritow, 1979); Competence Imagery and imaginal coping (Moran & 
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O'Brien, 2005); a combination of behavioural approaches and hypnotherapy (Wijesing, 1974) 
and CBT plus parent training (Kahana & Feeny, 2005). A further two treatment studies 
showed group and online CBT to be effective at reducing SPOV symptomatology (Ahlen et 
al., 2015), Sykes et al 2015). Online CBT was also associated with reductions in depression, 
anxiety and stress, and improvements in quality of life (Sykes et al, 2015). Other case reports 
suggest trauma focussed approaches are effective in cases where exposure is not feasible (de 
Jongh, 2012; de Jongh, Ten Broeke, & Renssen, 1999); however, there may be publication 
bias in single cases.  
Studies included in the current review suggest that CBT in group and individual format are 
effective at reducing SPOV symptomatology, anxiety and depression maintained at follow up 
with good effect sizes (Ahlen et al., 2015; Riddle-Walker et al., 2016). Group CBT was 
associated with clinically significant change in two thirds of participants at follow up, and 
high client satisfaction ratings (Ahlen et al., 2015). Repeated exposure and relaxation training 
(Philips, 1985) and parent contingency management were also associated with significant 
reductions in SPOV symptomatology maintained at follow up.  
Interestingly, only 25% of the 67% of patients referred to a psychiatrist or psychologist 
received some form of therapy for their SPOV (Veale & Lambrou, 2006). This review also 
highlights the breadth of treatment approaches that are currently being offered to patients 
with SPOV. Despite the evidence base supporting exposure as the treatment of choice for 
SPOV, it appears that a higher proportion of patients may be offered non-evidence based 
treatments such as hypnotherapy compared to CBT (35% vs 17.9%). Research into the 
effectiveness of treatment approaches has been found to be limited due to small sample sizes, 
high dropout rates, high levels of comorbidity and heterogeneity of cases (van Hout & 
Bouman, 2012; Veale & Lambrou, 2006). Two of four studies exploring the effectiveness of 
treatments for SPOV included in the review had relatively weak design (Klonoff et al., 1984; 
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Philips, 1985). These studies were found to have limitations relating to sampling bias, data 
collection methods, blinding and confounders, which supports previous findings.  
Treatment for SPOV currently focuses on graded exposure to internal cues such as nausea, 
vomit-related cues, or to activities that have previously been avoided (Veale, 2009). Due to 
heterogeneity in idiosyncratic fears in people with SPOV, it is essential that an individualised 
formulation is used to devise appropriate exposure tasks and behavioural experiments in 
order to target specific fears. SPOV may also require adapted treatment protocols compared 
to other phobias, due to difficulties with exposure to self-vomiting which is not easy to 
achieve, practical or evidence based. Furthermore, disgust may play a role in the development 
and maintenance of SPOV, as disgust is a universal reaction to vomiting, which in the case of 
SPOV may be amplified by fear. Therefore, interventions that target disgust as well as 
anxiety may be important at reducing symptomatology.  
Evidence supporting specific treatment components is limited. For example, there are no 
reported studies on the effectiveness or practicality of actual vomiting by the person with 
SPOV or willingness by the person with SPOV to agree to this approach. Therefore, it 
remains unknown to date whether exposure to internal or external cues is most effective at 
reducing SPOV symptomatology. Further controlled studies with robust methodology and 
larger sample sizes are therefore needed to evaluate the effectiveness of adapted 
psychological treatments for SPOV, such as targeting disgust, exposure through virtual 
reality or imagery rescripting of early aversive memories. Further research may need to 
evaluate the format of treatment delivery, e.g. treatment as usual compared to time intensive 
programmes of treatment. Lastly, it may be helpful to compare such treatment protocols to 
other types of credible therapy being offered, such as hypnotherapy.  
Limitations 
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Many of the included studies used community participants with self-reported fear of 
vomiting. For example, only one study exploring the phenomenology of SPOV used a 
reliable and valid diagnostic tool to assess participants. This suggests that participants may 
not be representative of treatment seeking samples, and therefore generalisability may be 
limited. Furthermore, the majority of the studies use relatively small sample sizes, which 
could affect the power and reliability of findings. Most studies were rated low quality (n=6) 
or weak (n=2) and medium quality (n=12) or moderate (n=2). Only two studies scored in the 
high quality range. Therefore the majority of the existing literature on SPOV may have high 
risk of bias in interpreting results. Lastly, there is a lack of randomised controlled treatment 
studies exploring the effectiveness of treatments for this patient group.   
In terms of review limitations, some studies were excluded on the basis of the publication 
language not being English (n=11) and one study was unavailable at the time of the search. 
These studies were beyond the scope of the current review to include and may mean that 
important information on SPOV has been omitted. 
Conclusions 
Relative to other Specific Phobias, SPOV is an understudied disorder (van Hout & Bouman, 
2012) and there is a lack of well-designed empirical studies across all areas of the literature. 
The current literature on SPOV includes relatively few studies based on community and 
internet samples, of low or medium quality. Furthermore, there are only four published 
treatment studies including one RCT, based on relatively small sample sizes.  Future research 
is needed to explore the phenomenology of SPOV in representative and large samples. In 
particular, high quality RCTs are needed in order to address the gaps in knowledge regarding 
effectiveness of psychological treatments in reducing SPOV symptomatology and distress. 
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Table 1a. Quality assessment ratings across observational studies using tool adapted from 
STROBE 
Paper Area 
studied 
Representativ
eness 
Sam
ple 
size 
Participa
tion rate 
Crite
ria 
for 
SPO
V 
Eligibil
ity 
criteria 
Tot
al 
Quali
ty 
ratin
g 
Davids
on 
2008 
Features 0 0 0 0 0 0 Low 
Himle 
1988 
Diagnosis 2 0 0 2 1 5 Medi
um 
Holler 
2013 
Features 0 0 0 0 1 1 Low 
Lelliott 
1991 
Features 2 0 3 0 0 5 Medi
um 
Lipsitz 
2001 
Features 0 0 2 0 0 2 Low 
Price 
2012 
Features 0 0 0 2 1 3 Medi
um 
van 
Hout 
2012 
Features 2 0 3 0 0 5 Medi
um 
van 
Overve
ld 2008 
Features 0 0 2 0 1 3 Medi
um 
 
Veale 
2006 
Features 0 1 0 0 1 2 Low 
Verwo
erd 
2016 
Features 0 0 0 0 0 0 Low 
Wu 
2015 
Features 0 1 0 0 1 2 Low 
Becker 
2007 
Epidemiol
ogy 
2 2 2 2 1 9 High 
Himle 
1990 
Aetiology 2 0 0 2 1 5 Medi
um 
Veale 
2013a 
Aetiology 0 0 0 2 1 3 Medi
um 
Norris 
2014 
Co-
morbidity 
2 0 3 0 1 6 High 
Sykes 
2015 
Co-
morbidity 
0 0 2 2 1 5 Medi
um 
Veale 
2015 
Co-
morbidity 
0 0 0 2 1 3 Medi
um 
Veale 
2012 
Co-
morbidity 
0 0 0 2 1 3 Medi
um 
Bosche
n 2013 
Measures 0 0 0 2 1 3 Medi
um 
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Veale 
2013b 
Measures 0 0 0 2 1 3 Medi
um 
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Table 1b. Quality assessment rating across intervention studies using EPHPP tool 
Paper Selectio
n bias 
Study 
design 
Confounde
rs 
Blindin
g 
Data 
collectio
n 
methods 
Withdrawa
ls and 
dropouts 
Global 
rating 
Ahlen 
2015 
Moderat
e 
Moderat
e 
Strong Weak Strong Strong Moderat
e 
Klonof
f 2009 
Moderat
e 
Moderat
e 
Weak Moderat
e 
Weak Strong Weak 
Philips 
1985 
Weak Moderat
e 
Weak Weak Strong Strong Weak 
Riddle
-
Walke
r 2016 
Weak Strong Strong Moderat
e 
Strong Strong Moderat
e 
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Table 2. Studies exploring diagnosis and phenomenology of SPOV (n=12). 
Author Area 
studied 
Study design/ 
Sample size 
Participant
s  
Mean 
age 
(SD) 
Measures Main 
findings 
Himle 
1988 
Diagnos
is 
Epidemiologi
cal study 
 
n=88 total 
 
n=8 choking-
vomit phobia 
Specific 
phobia 
patients 
(70.5% 
females, 
29.5% 
males) 
 
Mean age of 
onset:  
Choking-
vomit: 20.6 
(SD=14.8) 
Not 
stated 
Age of 
onset 
Gender 
Family 
history of 
phobias 
Clinical 
assessment 
based on 
DSM 
criteria 
See results 
section. 
Lelliott 
1991 
Diagnos
is / 
Features 
Epidemiologi
cal study 
 
Total sample 
n=567 
 
SPOV n=40 
Phobia 
patients 
(70% 
female) 
 
Mean age of 
onset:  
17 (SD=14) 
 
 
Not 
stated 
FQ 
 
WSAS 
Gender 
differences: 
Greater 
proportion of 
women in 
SPOV (70%) 
vs Social 
Phobia (SocP) 
Age of onset:  
SPOV 
significantly 
lower than 
Agoraphobia 
(AgP)  
Clinical 
ratings: 
SPOV more 
disabled in 
using public 
transport and 
going into 
crowded 
shops than 
SocP 
Lipsitz 
2001 
Features Epidemiologi
cal study 
 
n=56 
 
Online 
SPOV 
group 
(89.3% 
female, 
10.7% 
male) 
Mean age of 
31.4 
(9.7) 
Survey 
 
Triggers: 
45.2% of time 
fear triggered 
by external 
stimuli (e.g. 
sight of food) 
40.5% 
internal 
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onset:  
9.2 years 
(SD=5.0)  
Mean 
illness 
duration  
22 years 
(SD=11.4) 
 
 
stimuli (e.g. 
acid stomach) 
15% out of 
the blue 
 
 
Price 
2012 
Features Cross-
sectional 
study 
 
N=36 
 
 
SPOV 
patients 
(assessed by 
SCID) 
(94.4% 
females, 
5.6% males) 
 
Mean age 
onset:  
14.6 years 
(SD=7.3)  
 
34.4 
years 
(12.8) 
PDSQ 
SCID-I 
 
SPOVI 
EmetQ 
DS-R 
Imagery 
interview 
Clinical 
features: 
Mean days of 
nausea in last 
week = 3.1, 
SD=2.4 
Imagery: 
51.7% field 
perspective 
3.4% observer 
perspective 
44.8% both 
van 
Hout 
2012 
Features Cross-
sectional 
study 
 
Vomit-fearful 
(VF) group 
n=19 
 
Community 
fearful (CF) 
n=15 
 
Community 
control (CC) 
n=156 
Community 
groups 
 
VF 89.5% 
female, 
10.5% male 
CF 80% 
female, 
20% male 
CC 56.4% 
female, 
43.6% male  
 
Age of 
onset 
(mode): 
13-18 years 
VF 47.4 
years 
(14.6) 
 
CF 46.4 
years 
(17.8) 
 
CC 
25.2 
years 
(4.3)  
 
PDSQ  
 
Survey 
Emetophobi
a Inventory 
(developed 
by authors) 
 
 
Nausea 
100% VF 
group 
experienced 
nausea or 
gastric 
complaint 
when anxious 
 
Prevalence: 
Women 4: 1 
Men 
(significant 
difference) 
 
  
Holler 
2013 
Features Cross-
sectional 
study 
 
n=131 
 
Low and high 
nausea groups 
 
 
Patients 
with SPOV 
(assessed by 
questionnair
e) 
96.6% 
female, 
3.4% male  
 
Mean age of 
26.47 
years 
(6.7) 
 
 
Survey 
(designed 
by the 
authors) 
Nausea: 
80.9% 
reported 
nausea  
44.4% fear 
pre-dated 
nausea 
Situation 
nausea 
occurs: 
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onset:  
9.5 years 
(SD=6.4) 
 
 
Stress 67.2% 
Eating certain 
foods 52.5% 
Health-related 
52.3% 
Illness 46% 
Events at 
work 43.1%, 
relationships 
41.6%, family 
35.9% 
Eating 
behaviour 
and weight: 
37.4% 
underweight 
(BMI<19) 
High level of 
nausea 
observed in 
underweight 
group 
compared to 
overweight 
group  
Verwoer
d 2016 
Features Cross-
sectional 
study 
 
n=144 
 
High fear of 
vomiting 
n=35 
 
Low fear of 
vomiting n= 
38 
Non-clinical 
participants 
(77% 
female, 
23% male 
High: 89% 
female 
Low: 66% 
female) 
22.62 
years 
(7.12) 
Online task 
8 scripts of 
everyday 
scenarios 
relevant to 
SPOV, 
asked to 
rate danger, 
risk of 
contaminati
on and 
becoming 
ill (0 low to 
100 high) 
 
EmetQ 
 
DPSS-R 
Disgust 
Higher SPOV 
symptoms 
associated 
with higher 
disgust 
propensity 
and sensitivity 
Emotional 
reasoning: 
Overall ER 
for risk of 
becoming ill 
most 
pronounced 
for high EQ 
group 
Effects of 
disgust- and 
anxiety- 
based ER on 
fear of 
vomiting: 
Disgust and 
anxiety based 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
ER 
significantly 
predicted high 
and low fear 
of vomiting 
Veale 
2006 
Features Cross 
sectional 
study 
 
SPOV n=100  
 
Panic disorder 
(PD) n=28 
 
Controls n=81 
SPOV (self-
reported) 
(97% 
female, 3% 
male 
Panic 
Disorder 
61% 
female, 
39% male  
Controls 
48% 
female, 
52% male)  
Mean age 
SPOV 
onset: 
9.8 years 
(6.9) 
Mean 
illness 
duration: 
25.9 years 
(13.9) 
SPOV 
37.61 
years 
(11.65) 
PD 
36.21 
years 
(12.98) 
Control
s 41.75 
years 
(14.72) 
Vomit 
Questionnai
re (versions 
for each 
group) 
 
Safety 
Behaviours 
Questionnai
re 
Panic 
Cognitions 
Questionnai
re 
 
BAI 
 
 
Symptoms 
SPOV 
reported 
feeling 
significantly 
more 
nauseous and 
higher anxiety 
Safety 
seeking 
behaviours 
SPOV 
significantly 
more likely to 
look for an 
escape route, 
control 
behaviour, 
take 
medication, 
read, suck 
mints, move 
very slowly 
than PD 
PD 
significantly 
more body 
checking 
van 
Overvel
d 2008 
Features Cross-
sectional 
study 
 
SPOV n=133 
 
Control n=43 
Internet 
SPOV 
group (self-
report) 
91.7% 
female, 
8.3% male 
 
Control  
93% 
female, 7% 
men 
 
 
SPOV 
25.4 
years, 
(SD=8.
2) 
 
Control 
24.7 
years, 
(SD=5.
9) 
 
DPSS-R 
DQ 
DS 
 
Emetophobi
a 
Questionnai
re 
 
 
 
 
Emetophobic 
complaints 
SPOV group 
had 
significantly 
more 
emetophobic 
complaints 
and vomit-
related 
avoidance 
behaviour, 
and 
significantly 
elevated 
levels of 
disgust 
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propensity 
and sensitivity 
compared to 
controls 
Disgust 
sensitivity 
best predictor 
of SPOV 
complaints, 
and avoidance 
and 
consequences 
of vomiting 
scores 
Davidso
n 2008 
Features Cross-
sectional 
study 
SPOV n=51 
Phobia 
controls (PC) 
n=48 
Controls n=50 
SPOV 
group 
(self-report) 
(100% 
female) 
SPOV 
31.56 
years 
(range 
15 -70)  
PC 
23.44 
years 
(range 
17-57)  
Control
s  
20.89 
years 
(range 
17-57)  
RLoCS 
HLoCS 
SPOV group 
had 
significantly 
higher internal 
general and 
health-related 
LoCS score 
compared to 
two control 
groups 
 
  
Wu 
2015 
Features Cross-
sectional 
study 
 
n=305  
Caregivers 
of youths 
aged 4-17 
years  
(Youths 
58.4 % 
female) 
Carers 
34.94 
years 
(8.59) 
 
Youths 
8.63 
years 
(3.42) 
SPOVI 
 
BESS 
 
HAI 
 
OCI-CV 
Incidence 
and 
phenomenolo
gy of SPOV 
23.67% trying 
to prevent 
self-vomiting 
9.63% avoid 
people 
10.03% avoid 
situations or 
activities 
 
SocP, Social Phobia; AgP, Agoraphobia; FQ, Fear Questionnaire; WSAS, Work and Social 
Adjustment Scale; PDSQ, Psychiatric Diagnostic Screening Questionnaire; SCID-I, 
Structured Clinical Interview for DSM-V; SPOVI, Specific Phobia of Vomiting Inventory; 
EmetQ, Emetophobia Questionnaire; DS-R, Disgust Scale Revised; DPSS-R, Disgust 
Propensity and Sensitivity Scale Revised; BAI, Beck Anxiety Inventory; DQ, Disgust 
Questionnaire; DS, Disgust Scale; BESS, Behavioural and Emotional Screening System; 
HAI, Health Anxiety Inventory; OCI-CV, Obsessive Compulsive Inventory – Child Version; 
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RLoCS, Rotter’s Locus of Control Scale; HLoCS, Health Locus of Control Scale; ED, Eating 
Disorder 
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Table 3. Phenomenology of SPOV reported across studies.  
Locus of fear 
Self  Others Self=others Public Privat
e 
Public=
private 
   
47.3 
(366) 
12.7 
(331) 
35.5 (699) 47.9 
(409) 
3 
(166) 
55.6 
(188) 
   
Feared outcomes 
Becom
ing ill 
Nausea/v
omiting 
Heart attack Panic Losin
g 
contro
l 
Vomit 
(sound, 
sight, 
smell 
taste) 
Self-
disgust 
Suffoc
ation 
Gaggi
ng 
50.5 
(113) 
23.9 
(113) 
30.4 (128) 29.4 
(34) 
19.1 
(165) 
71.5 
(131) 
72.3 
(131) 
66.1 
(131) 
4.8 
(131) 
33.6 
(131) 
37.3 
(131) 
83.8 
(131) 
Safety seeking behaviours 
Expiry 
dates 
Hand 
washing 
Checking 
health 
Checkin
g 
others’ 
health 
Postp
oning 
pregn
ancy 
Overco
oking 
food 
Eating 
rituals 
Reass
ure 
self 
Reassu
rance 
seekin
g 
64.9 
(296) 
42.1 
(183) 
16 (100) 80.8 
(83) 
44.9 
(211) 
62.4 
(94) 
40.3 
(233) 
52.7 
(83) 
30 
(183) 
Avoidance behaviours 
Sick 
people 
Drunk 
people  
Foreign 
countries 
Alcohol Food Illegal 
substan
ces 
Travel 
by boat 
Travel 
by 
plane 
Public 
transp
ort 
80.8 
(119) 
85.9 
(119) 
71.1 (119) 65.6 
(119) 
84.6 
(167) 
92.3 
(100) 
89.3 
(100) 
68.7 
(100) 
64.4 
(100) 
Food related avoidance 
Salad 
bars/b
uffets 
Restaura
nts 
Pubs Foreign 
foods 
Shellf
ish 
Meat Fish Dairy Eggs 
63.1 
(100) 
54.1 
(100) 
55.65 (100) 32.1 
(194) 
65.7 
(194) 
45.6 
(325) 
14.4 
(131) 
17.6 
(325) 
22.3 
(225) 
Past treatment 
GP Medicati
on 
Referral to 
psychology/
psychiatry 
Psychot
herapy 
CBT BT Hypnot
herapy 
  
74.5 
(231) 
38.7 
(156) 
67 (100) 25.8 
(175) 
17.9 
(100) 
20.3 
(100) 
35 
(100) 
  
CBT, Cognitive Behavioural Therapy; BT, Behavioural Therapy. NB: Averages in bold are 
weighted averages calculated across studies 
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Table 4. Studies exploring epidemiology, aetiology and comorbidity (n=7) 
Author Area 
studied 
Study design Participan
ts 
Mean 
Age 
(SD) 
Measures Main 
findings 
Himle 
1990 
Aetiology Epidemiologi
cal study 
 
n=84 total 
  
n=10 
choking-
vomit 
Specific 
phobia 
patients 
(75% 
female, 
25% 
male)  
 
Mean age 
of onset:  
13.9 years 
21.8 
years 
 
Mode of 
onset 
(realistic 
threat, 
vicarious 
learning, 
spontaneous
, lifelong, 
gradual) 
Mode of 
onset  
mode-of-
onset: 
Realistic 
threat 
(n=38), 
vicarious 
learning 
(n=9), 
spontaneous 
(n=20), 
lifelong 
(n=5), 
gradual 
(n=6) 
Choking/vo
mit group 
realistic 
threat (67%) 
Lipsitz 
2001 
Aetiology Epidemiologi
cal study 
 
n=56 
 
Online 
SPOV 
group 
(89.3% 
female, 
10.7% 
male) 
Mean age 
of onset:  
9.2 years 
(SD=5.0)  
Mean 
illness 
duration  
22 years 
(SD=11.4
) 
31.4 
(9.7) 
Survey 
 
Aetiology: 
29% recalled 
severe or 
vivid bouts 
of vomiting 
59% others 
vomiting 
20% both 
vomiting on 
own and 
observing 
others 
Veale 
2013a 
Aetiology Cross-
sectional 
study 
 
SPOV n=94  
Control n=90 
 
SPOV 
patients 
(identified 
by PDSQ 
& SCID) 
SPOV 
93.6% 
SPOV 
32.3 
years 
(11.7) 
 
Contro
l 32.5 
Self-report 
questionnair
e recalling 
each 
episode 
vomiting 
(self or 
Memories 
of vomiting 
No 
difference in 
number of 
memories of 
self-
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female, 
6.4% 
male 
Control 
96.7% 
female, 
3.3% 
male 
Mean age 
onset:  
15.7 years 
(SD=7.3) 
 
 
years 
(11.0) 
 
others) vomiting 
before age of 
onset  
SPOV group 
recalled 
significantly 
less episodes 
of self-
vomiting 
after age of 
onset, and 
significantly 
more of 
others 
vomiting 
before and 
after age of 
onset 
SPOV group 
rated 
memories as 
significantly 
more 
distressing  
 
Verwoer
d 2016 
Aetiology Cross-
sectional 
study 
 
n=144 
 
High fear of 
vomiting 
n=35 
 
Low fear of 
vomiting n= 
38 
Non-
clinical 
participan
ts 
(77% 
female, 
23% male 
High: 
89% 
female 
Low: 66% 
female) 
22.62 
years 
(7.12) 
Online task 
8 scripts of 
everyday 
scenarios 
relevant to 
SPOV, 
asked to 
rate danger, 
risk of 
contaminati
on and 
becoming ill 
(0 low to 
100 high) 
EmetQ 
DPSS-R 
Disgust 
based ER 
may play a 
role in the 
development 
of SPOV e.g. 
using 
feelings of 
disgust to 
infer risk of 
becoming ill 
may 
contribute to 
the 
persistence 
of erroneous, 
phobic 
beliefs 
 
Davidso
n 2008 
Co-
morbidity 
Cross-
sectional 
study 
 
SPOV n=51 
Phobia 
SPOV 
group 
(self-
report) 
(100% 
female) 
SPOV 
31.56 
years 
(range 
15 -70)  
PC 
RLoCS 
HLoCS 
Co-
morbidity 
Almost half 
reported 
additional 
mental 
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controls (PC) 
n=48 
Controls n=50 
23.44 
years 
(range 
17-57)  
Contro
ls  
20.89 
years 
(range 
17-57)  
health issues 
e.g. GAD 
and OCD 
(most 
common), 
panic 
disorder, 
depression, 
n=4 anorexia 
nervosa  
 
 
 
 
 
 
 
 
Norris 
2014 
Co-
morbidity 
Retrospective 
review 
 
n=205  
 
AN sample 
n=36  
 
Adolesce
nt ED 
patients  
Gender 
ARFID: 
79% 
female, 
21% male 
AN: 92% 
female, 
8% male 
Mean 
illness 
duration: 
12 years 
(SD=8) 
ARFID
: 13.7 
(2.5) 
 
AN: 
14.9 
(1.9) 
Clinical 
features 
(Diagnostic 
criteria) 
5% met 
criteria for 
ARFID  
 
Among 
ARFID 
sample, 
26.5% had 
fear of 
vomiting and 
17% 
experienced 
nausea  
Sykes 
2015 
Co-
morbidity 
Cross-
sectional 
study 
 
n=64 
SPOV 
participan
ts  
(assessed 
by SCID)  
(85.9% 
female, 
14.1% 
male) 
32.2 
years 
(8.1) 
SCID All 64 
participants 
had SPOV 
diagnosis 
 
See Table 5 
for co-
morbidity 
rates 
van 
Hout 
2012 
Co-
morbidity 
Cross-
sectional 
study 
 
Vomit-fearful 
(VF) group 
n=19 
 
Communi
ty groups 
 
VF 89.5% 
female, 
10.5% 
male 
CF 80% 
VF 
47.4 
years 
(14.6) 
 
CF 
46.4 
years 
PDSQ  
 
Survey 
Emetophobi
a Inventory 
(developed 
by authors) 
 
Rates of 
additional 
psychiatric 
complaints 
in vomit-
fearful group 
significantly 
higher than 
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Community 
fearful (CF) 
n=15 
 
Community 
control (CC) 
n=156 
female, 
20% male 
CC 56.4% 
female, 
43.6% 
male  
 
Age of 
onset 
(mode): 
13-18 
years 
(17.8) 
 
CC 
25.2 
years 
(4.3) 
  
 
 community 
groups 
 
See Table 5 
for co-
morbidity 
rates 
Veale 
2012 
Co-
morbidity 
Cross 
sectional 
study 
 
n=94  
Restricting 
food (SPOV-
R, n=32)  
Not restricting 
food (SPOV-
NR, n=62) 
SPOV 
patients 
(assessed 
by SCID) 
(93.6% 
female, 
6.4% 
male) 
 
 
Total 
32.6 
years 
(12.1) 
 
SPOV-
R 32.5 
years 
(11.3) 
SPOV-
NR 
32.7 
years, 
(12.6) 
 
PDSQ 
 
Fear of 
vomiting 
questionnair
e 
SPOVI 
 
DS-R 
OCI 
HAI 
PHQ-9 
GAD-7 
WSAS 
100% had 
diagnosis of 
SPOV 
See Table 5 
for co-
morbidity 
rates.  
Restricters 
had 
significantly 
lower BMI  
3.7% of total 
sample had 
BMI <17.5 
Restricters 
reported 
more nausea, 
SPOV 
symptoms, 
avoidance of 
eating 
situations 
and foods, 
severity of 
anxiety & 
handicap 
Veale 
2015 
Co-
morbidity 
Cross 
sectional 
study 
 
n=83 
Patients 
with 
SPOV 
(assessed 
by SCID) 
 
86.7% 
females, 
13.3% 
males 
 
Mean age 
29.42 
years 
(10.42) 
 
Scales to 
measure 
repetitive 
thinking and 
repetitive 
behaviours 
 
SPOVI 
EmetQ 
 
HAI 
 
Health 
Anxiety 
Mean score 
above cut-
off 
suggesting 
relationship 
between 
SPOV 
symptoms 
and health 
anxiety  
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of onset 
8.2 years 
(SD=5.21
) 
 
Mean 
illness 
duration  
14.25 
years 
(SD=11.6
9) 
 Repetitive 
thinking 
62.5% 
severely 
preoccupied 
by worry of 
vomiting 
Correlations 
between 
severity of 
SPOV and 
frequency of 
hand 
washing 
Late onset 
associated 
with more 
frequent 
hand 
washing 
Becker 
2007 
Epidemiolo
gy 
Prospective 
epidemiologic
al study 
 
n=2064 
Communi
ty sample 
(aged 18-
24 years) 
100% 
female 
Mean age 
of onset  
7.5 years 
(SD=5.20
) 
 
Mean 
illness 
duration: 
12.75 
years 
(SD=6.85
) 
Not 
stated 
F-DIPS Lifetime 
prevalence 
of SP = 
12.8% 
 
SPOV 
prevalence 
rates: 
Lifetime 
0.2% 
12 month 
0.2% 
Point 0.1% 
PDSQ, Psychiatric Diagnostic Screening Questionnaire; ED, Eating Disorder; AN, Anorexia 
Nervosa; ARFID, Avoidant and Restrictive Feeding Disorder; F-DIPS, “Diagnostisches 
Interview bei Psychischen Störungen—Forschungsversion” (translation: Diagnostic Interview 
for Mental Disorders—Research Version); SP, Specific Phobia; SCID, Structured Clinical 
Interview for DSM; F-DIPS 
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Table 5. Comorbidity rates reported across studies  
Author Average % 
 
n 
 
None 59.5 348 
One 27.7  414 
Two or more 15.9  414 
Specific Phobia 4.1  581 
Agoraphobia 5.5  486 
Panic disorder 10.2  600 
Major depressive disorder 13.6  636 
Bipolar disorder 0  64 
Social phobia 10.1  542 
Obsessive compulsive disorder 9.6  617 
Childhood separation anxiety 57  56 
Generalised anxiety disorder 14.1  478 
Health anxiety 2.8  319 
Somatisation disorder 7.3  497 
Hypochondriasis 5.9  159 
Post traumatic stress disorder 1.4  147 
Body dysmorphic disorder 1.6  64 
Personality disorder 2.4  83 
Eating disorder 1.1  177 
NB: Averages in bold are weighted averages of percentages calculated across studies 
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Table 6. Studies exploring assessment measures and effectiveness of psychological 
treatments for SPOV (n=6)  
Auth
or 
Area 
studies 
Study 
design/ 
Sample 
size 
Partici
pants 
Mean 
age 
(SD) 
Type of outcome 
measure 
 
 
Interve
ntion 
(type, 
dose, 
duratio
n and 
frequen
cy vs 
placebo 
type 
dose 
duratio
n and 
frequen
cy) 
Main 
findings 
Bosc
hen 
2013 
Assess
ment 
measur
es 
Cross-
sectiona
l study 
 
SPOV 
n=95 
 
Healthy 
control 
(HC) 
n=90 
 
Anxiou
s 
control 
(AC) 
n=20 
 
SPOV 
patients 
(diagno
sed by 
SCID) 
(93.7% 
female) 
 
HC 
(95.6% 
female) 
 
AC 
(100% 
female) 
SPOV 
32.61 
years 
(12.09) 
 
HC 
32.45 
years 
(11.0) 
 
AC 
29.01 
years 
(7.13) 
 
 
Behavioural test 
assessing ability to 
approach a vomit-like 
stimulus  
SPOVI 
EmetQ-13 
 
DS-R 
 
OCI 
 
PHQ-9 
GAD-7 
HAI 
WSAS 
 
N/A Emet-Q 
found to 
have 
good 
internal 
consiste
ncy, 
good test 
re-test 
reliabilit
y, good 
sensitivit
y and 
diagnosti
c 
specificit
y  
Veal
e 
2013
b 
Assess
ment  
measur
es 
Longitu
dinal 
study 
 
SPOV 
n=95 
 
Commu
nity 
n=90 
SPOV 
group 
(assesse
d by 
SCID) 
93.7% 
female, 
6.3% 
male 
 
Commu
nity 
96.7% 
female, 
Mean 
age 
SPOV: 
32.61 
years 
(12.09) 
 
Commu
nity: 
32.47 
years 
(11.0) 
SPOVI 
EmetQ-13 
 
DS-R 
 
OCI 
HAI 
PHQ-9 
GAD-7 
WSAS 
N/A SPOVI 
was 
found to 
have 
good 
internal 
consiste
ncy, test 
re-test 
reliabilit
y, 
concurre
nt and 
converge
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3.3% 
male 
nt 
validity, 
and 
sensitivit
y to 
change 
during 
treatmen
t.  
 
Ahle
n 
2015 
Treatm
ent 
Longitu
dinal 
cohort 
design 
 
 
23 
SPOV 
patients 
(assesse
d by 
MINI) 
(96% 
female) 
 
Mean 
age of 
onset  
16 
years 
(SD = 
8.4) 
 
Mean 
illness  
duration  
15 
years 
(SD = 
10.6) 
32.3 
years 
(8.1) 
EmetQ 
 
BAI 
 
MADRS-S 
 
CSQ-8 
Format: 
Group  
 
Content
: CBT 
 
Intensit
y: 
weekly 
2.5 hr 
sessions
, 10 
weeks, 
one 
follow 
up 
session. 
Sympto
ms 
Significa
nt 
reductio
n in 
SPOV 
sympto
ms, 
anxiety 
and 
depressi
on over 
time 
 
Clinical 
significa
nce 
48% 
clinicall
y 
significa
ntly 
improve
d  
67% 
clinicall
y 
significa
ntly 
improve
d at 
follow-
up. 
 
  
Klon
off 
2009 
Treatm
ent 
Longitu
dinal 
cohort 
study 
5 SPOV 
patients  
(80% 
female, 
10.5 
years 
 
Parents & child 
symptom  
frequency ratings 
 
Content
: 
Conting
ency 
All 
patients 
sympto
m-free 
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 20% 
male) 
manage
ment, 
parent 
training 
and 
relaxati
on  
post 
treatmen
t, 
maintain
ed at 
follow-
up (6 to 
18 
months). 
Phili
ps 
1985 
Treatm
ent 
Longitu
dinal 
cohort 
design 
7 SPOV 
patients 
(71.4% 
female, 
28.6% 
male) 
Mean 
age of 
onset 
8.5 
years 
Mean 
illness 
duration 
17.4 
yrs.  
29.9 
years 
Behaviour tests 
Approach simulated 
patch of  
vomit, and watching 
film sequence  
of someone vomiting. 
FSS 
FNE 
BDI 
Format: 
Group  
 
Content
: ERP 
and 
relaxati
on 
 
Intensit
y: 
weekly 
1 hr 
sessions
, 8-13 
weeks. 
Sympto
ms 
Reductio
n in fear 
and 
depressi
on over 
time  
Improve
ments 
maintain
ed at 6 
month 
follow-
up. 
Ridd
le-
Wal
ker 
2016 
Treatm
ent 
RCT 
 
12 
SPOV 
patients 
(CBT 
group) 
12 
SPOV 
patients  
(Contro
l group)  
 
 
CBT 
group 
35 
years 
(8) 
 
Wait 
list 
32 
years 
(17) 
 
SPOVI 
EmetQ 
 
HAI 
 
ASI 
 
PHQ-9 
 
SDS 
Format: 
individu
al  
 
Content
: CBT, 
imagery 
rescripti
ng  
 
Intensit
y: 12x 
60 
minute 
sessions  
Group 
differen
ces 
Significa
ntly 
lower 
SPOVI 
& 
EmetQ, 
and in 
CBT 
group 
than 
control 
group 
post-
treatmen
t   
Clinical 
significa
nce 
Significa
ntly 
more 
participa
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nts in 
CBT 
group 
achieved 
reliable 
improve
ment and 
clinicall
y 
significa
nt in 
SPOV 
sympto
ms 
compare
d to 
those in 
wait list 
group  
DS-R, Disgust Sensitivity Revised; OCI, Obsessive Compulsive Inventory; PHQ-9, Patient 
Health Questionnaire; GAD7, Generalised Anxiety Disorder Questionnaire; HAI, Health 
Anxiety Inventory; WSAS, Work and Social Adjustment Scale; ASI, Anxiety Sensitivity 
Index; FSS, Fear Survey Schedule; FNE, Fear of Negative Evaluation; ERP, Exposure and 
Response Prevention; SDS, Sheehan Disability Scale; SCID, Structured Clinical Interview 
for DSM-IV; MINI, Mini-international neuropsychiatric interview; EmetQ, Emetophobia 
Questionnaire; SPOVI, Specific Phobia of Vomiting Inventory; BAI, Beck Anxiety 
Inventory; MADRS-S, Montgomery–Åsberg Depression Rating Scale—self assessment; 
BDI, Beck Depression Inventory; CSQ-8, Client Satisfaction Questionnaire 
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Appendix A.  
 
Paper:   
 Reviewer:   
 
    
Scor
e 
Representativeness   
1. What kind of recruitment strategy has 
been used? Randomized/consecutive (2)   
  Non-randomized/convenience (0)   
  Not stated (0)   
Sample size   
2. What is the sample size? 50-149 (0)   
  150-399 (1)   
  400+ (2)   
Participation rate   
3. Is the participation rate reported? Yes (2)   
  No (0)   
4. Is participation rate >75%? Yes (1)   
  No (0)   
Criteria for Specific Phobia   
5. How has specific phobia been detected? 
Structured/semi structured clinical 
interview (2)   
  Screening tool (0)   
Eligibility criteria   
6. Have eligibility criteria been specified? Yes (1)   
  No (0)   
      
Total   
 Overall rating    
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Appendix B.  
 
Author/year:   
Reviewer:   
COMPONENT RATING 
A. Selection bias 
1. Are the individuals selected to participate in the study likely to be representative of 
the target population?     
2. What percentage of selected individuals agreed to participate?     
Section rating     
B. Study Design 
1. Indicate the study design     
2. Was the study described as randomized? If NO, go to Component c.     
3. If YES, was the method of randomization described?     
4. If YES, was the method appropriate?     
Section rating     
C. Confounders 
1. Were there important differences between groups prior to intervention?     
2. If YES, indicate the percentage of relevant confounders that were controlled (either 
in design or analysis)     
Section rating     
D. Blinding 
1. Was (were) the outcome assessor(s) aware of the intervention or exposure status of 
participants?     
2. Were the study participants aware of the research question?     
Section rating     
E. Data collection methods 
1. Were data collection tools shown to be valid?     
2. Were data collection tools shown to be reliable?     
Section rating     
 
 
 
F. Withdrawals and dropouts 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
1. Were withdrawals and drop-outs reported in terms of numbers and/or reasons per 
group?     
2. Indicate the percentage of participants completing the study (if % differs by group, 
report the lowest)     
Section rating     
G. Intervention integrity 
1. What percentage of participants received the allocated intervention or exposure of 
interest?     
2. Was the consistency of the intervention measured?     
3. Is it likely that subjects received an unintended intervention (contamination or co-
intervention) that may influence results?     
H. Analyses 
1. Indicate the unit of allocation     
2. Indicate the unit of analysis     
3. Are the statistical methods appropriate for the study design?     
4. Is the analysis performed by intervention allocation status (i.e. intention to treat) 
rather than the actual intervention received?     
   
   GLOBAL RATING 
 A. Selection bias   
 B. Study design   
 C. Confounders   
 D. Blinding   
 E. Data collection method   
 F. Withdrawals and dropouts   
 GLOBAL RATING   
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Figure 1. PRISMA (2009) Flow Diagram 
Records identified through database searching 
(n = 385  ) 
Sc
re
en
in
g 
In
cl
u
d
ed
 
El
ig
ib
ili
ty
 
Id
en
ti
fi
ca
ti
o
n
 
Additional records identified through other 
sources (n =  3 ) 
Records after duplicates removed 
(n = 308 ) 
Records screened 
(n =  308 ) 
Records excluded 
(n =  237 ) 
n=228 not researching SPOV 
n=5 not research articles  n=1 non-
psychological intervention 
Full-text articles assessed for 
eligibility 
(n =  71 ) Full-text articles excluded 
(n =  47 ) 
n=1 unavailable 
 n=7 not SPOV 
n=11 not in English  
n=28 research design Studies included in qualitative 
synthesis (n = 24 ) 
No meta-analysis was conducted 
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Highlights 
 The first systematic review of existing literature on Specific Phobia of Vomiting 
 Lack of research compared to other phobias, especially into effective interventions 
 RCTs needed to evaluate effective treatments and comparison to other approaches 
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